Quotes Newron Pharmaceuticals S.p.A. Deutsche Boerse AG
Stocks
NP5
IT0004147952
Biotechnology & Medical Research
|
Real-time Estimate
Tradegate
22:12:02 01/10/2026 +04
|
5-day change | 1st Jan Change | ||
| 8.790 EUR | -3.19% |
|
-18.62% | -64.58% |
Stock exchange
Deutsche Boerse AG
NP5 9.440 €
+3.96%
47.2
€
| Markets | Price | Change | Volumes | ||
|---|---|---|---|---|---|
| NWRN | 8.180CHF | +1.61% | 992K CHF | ||
Tradegate
| NP5 | 8.820EUR | +4.26% | 90.53K € | |
|
Xetra
| NP5 | 8.720EUR | +2.59% | 45.47K € | |
|
CBOE
| 0QOI | 8.270CHF | +3.12% | 18.43K CHF | |
|
Börse Stuttgart
| NP5 | 8.800EUR | +4.27% | 1.75K € | |
|
Deutsche Boerse AG
| NP5 | 9.440EUR | +3.96% | 47.2 € | |
|
Boerse Muenchen
| NP5 | 8.820EUR | +4.26% | 26.46 € |
Quotes 5-day view: Newron Pharmaceuticals S.p.A.
Delayed Quote Deutsche Boerse AG
| 25/09/2026 | 28/09/2026 | 29/09/2026 | 30/09/2026 | 01/10/2026 | |
|---|---|---|---|---|---|
| Last | €10.50 | €8.200 | €8.200 | €9.080 | €9.440 |
| Volume | 0 | 8,300 | 0 | 400 | 5 |
| Change | -9.48% | -21.90% | 0.00% | +10.73% | -3.19% |
| Opening | €11.40 | €9.900 | €8.200 | €8.400 | €8.260 |
| High | €11.40 | €9.900 | €8.200 | €9.080 | €9.440 |
| Low | €10.50 | €8.200 | €8.200 | €8.400 | €8.260 |
Performance
| 1 day | -3.19% | ||
| 1 week | -18.62% | ||
| Current month | +3.96% | ||
| 1 month | -27.10% | ||
| 3 months | -32.33% | ||
| 6 months | -42.58% | ||
| Current year | -64.58% | ||
| 1 year | -17.19% | ||
| 3 years | +73.21% | ||
| 5 years | +383.61% | ||
| 10 years | +21.95% |
Volumes
marketsDaily volume
5
Estimated daily volume
6
Avg. Volume 20 sessions
616
Daily volume ratio
0.01
Avg. Volume 20 sessions
5,414.64
Avg. Volume 20 sessions USD
6,078.91
Record volume 1
31,741
Record volume 2
27,594
Record volume 3
23,216
Capital turnover ratio
0
Float rotation
0
Basic data
Market Cap (EUR)
182,009,866
Market Cap (USD)
204,919,912
Net sales (EUR)
19,126,000
Net sales (USD)
21,533,438
Number of employees
27
Sales / Employee (EUR)
708,370
Sales / Employee (USD)
797,535
Free-Float
87.16%
Free-Float capitalization (EUR)
158,642,494
Free-Float capitalization (USD)
178,611,230
Average Daily Capital Traded
-.--%
Indicators
Moving average 5 days
9.516
Moving average 20 days
11.6
Moving average 50 days
12.4
Moving average 100 days
12.98
Price spread / (MMA5)
+8.26%
Price spread / (MMA20)
+32.00%
Price spread / (MMA50)
+41.13%
Price spread / (MMA100)
+47.65%
STIM
RSI 9 days
19.46
RSI 14 days
23.99
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -3.19% | -18.62% | -17.19% | +73.21% | 205M | |
| +4.16% | -0.36% | +49.37% | +94.17% | 74.46B | |
| -0.61% | +0.81% | +27.25% | +80.21% | 60.14B | |
| -2.54% | -1.65% | +4.86% | +33.32% | 48.15B | |
| -2.44% | -5.48% | +27.56% | +34.08% | 44.25B | |
| +1.35% | +3.74% | +352.12% | +692.28% | 43.99B | |
| -1.43% | -0.08% | +7.32% | +101.51% | 41.61B | |
| +3.32% | +3.49% | +11.18% | +51.23% | 29.97B | |
| +4.77% | +6.16% | +36.77% | +22.78% | 29.31B | |
| -3.38% | -9.42% | -25.24% | +333.98% | 24.93B | |
| Average | +0.01% | +1.97% | +47.40% | +151.68% | 39.7B | |
| Weighted average by Cap. | +0.50% | +1.83% | +58.80% | +151.56% |
Historical Quotes: Newron Pharmaceuticals S.p.A.
| Date | Opening | High | Low | Close | Volume | Change |
|---|
Latest transactions
e6c.QsJ-6QpeRd4r3cYACLyxymlxaw8eBMSvr4pNMYsazsc.C4gpnH8rPY5plKU1QtDhrhAGCmQpTPXWnuU9Xbx1ha4nkAyDRRlxm2Szkw
| Date | Price | Volume | Total |
|---|---|---|---|
| 17:08:35 | 9.440 | 2 | 5 |
Price Extremes
| 1 week | 8.2 |  | 11.4 |
| 1 month | 8.2 | | 13.15 |
| Current year | 8.2 | | 33.55 |
| 1 year | 8.2 | | 33.55 |
| 3 years | 4.2 | | 33.55 |
| 5 years | 1 | | 33.55 |
| 10 years | 1 | | 33.55 |
Monthly variations
Annual variations
| 2026 | -65.93% | ||
| 2025 | +186.87% | ||
| 2024 | +65.89% | ||
| 2023 | +280.95% | ||
| 2022 | -2.13% | ||
| 2021 | -21.44% | ||
| 2020 | -66.46% | ||
| 2019 | -55.10% | ||
| 2010 | +1.64% | ||
| 2009 | +35.61% | ||
| 2008 | -66.64% | ||
| 2007 | -16.74% | ||
| 2006 | +2.03% |
- Stock Market
- Stocks
- NWRN Stock
- NP5 Stock
- Quotes Newron Pharmaceuticals S.p.A.
Select your edition
All financial news and data tailored to specific country editions
